In fact, patients with MDD express increased levels of proinflammatory cytokines like interleukin (IL)-1, IL-6 and tumor necrosis factor (TNF)-α in peripheral blood, which can access the central nervous system (CNS) and activate tissue-resident macrophages like microglia, impair HPA axis function, modulate monoaminergic neurotransmission, and reduce neural plasticity11–13. The gene discussed is IL6; the disease is major depressive disorder.